Results 191 to 200 of about 2,778,280 (294)

Long‐Term Use of Rezafungin: A Case Report and Insights Into Real‐World Access

open access: yes
Transplant Infectious Disease, EarlyView.
Jian Mei Li   +2 more
wiley   +1 more source

Genome‐Wide Analysis of Resistance to Gastrointestinal Parasites in Portuguese Merino and Merino‐Related Sheep

open access: yesAnimal Genetics, Volume 57, Issue 6, December 2026.
ABSTRACT Gastrointestinal nematodes (GIN) are one of the main constraints affecting sheep production worldwide. For decades, control methods based on anthelmintics have been extensively used, which ended up in multiple drug‐resistant helminth strains.
Daniel Gaspar   +13 more
wiley   +1 more source

Metabolomics Insights Into Nutritional Intervention With Polyphenols in Feedlot Beef Cattle

open access: yesNew Zealand Journal of Agricultural Research, Volume 69, Issue 6, December 2026.
Polyphenol‐based feed additives have been increasingly used in feedlot diets due to their potential to modulate rumen fermentation and systemic redox and inflammatory responses; however, mechanistic evidence at the systemic level in finishing cattle remains limited.
Lauro César Ferreira Beltrão   +12 more
wiley   +1 more source

Conservative Management of Presumptive Free Flap Pedicle Compromise on Postoperative Day 6: Report of Two Cases and Literature Review

open access: yesMicrosurgery, Volume 46, Issue 8, December 2026.
ABSTRACT Pedicle compromise after free tissue transfer typically mandates urgent surgical re‐exploration, as flap viability is considered entirely dependent on an intact vascular supply before inosculation is achieved. Whether selective conservative management can be considered in selected cases remains an open question.
Filippo A. G. Perozzo   +5 more
wiley   +1 more source

Internal Jugular Vein Valve—Not to Be Ignored [PDF]

open access: yesJournal of Cardiothoracic and Vascular Anesthesia, 2017
openaire   +2 more sources

A Biweekly GLP‐1R Agonist Designed With Drug‐Free Intervals for Enhanced Efficacy, Receptor Homeostasis and Gastrointestinal Tolerability

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 12, Page 11143-11177, December 2026.
ABSTRACT Aim To develop a next‐generation, longer‐acting, more‐clinical‐benefits agonist to achieve sustained efficacy with improved tolerability. Methods CT130 was designed from semaglutide. Binding affinity was validated via molecular dynamics and cellular assays.
Wei Ding   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy